Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure

被引:27
|
作者
Samouilidou, E
Grapsa, E
机构
[1] Alexandra Hosp, Biochem Dept, GR-11528 Athens, Greece
[2] Alexandra Hosp, Renal Unit, GR-11528 Athens, Greece
关键词
hemodialysis; peritoneal dialysis; total antioxidant capacity; malonaldehyde; 4-hydroxyalkenals;
D O I
10.1159/000070691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. This study focuses on the comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation products in patients on hemodialysis (HD) before and after treatment and in peritoneal dialysis (PD) patients. Plasma TAC, malonaldehyde (MDA), and 4-hydroxyalkenal concentrations were measured in 31 HD patients, in 24 PD patients, and in 17 normal controls (NC). It was found that before HD, TAC and MDA levels were higher than those in the NC (p < 0.001). After HD, these levels decreased significantly but were higher than in NC and lower than in PD patients (p < 0.001). The levels of 4-hydroxyalkenals were elevated in patients as compared with NC, but did not differ between HD and PD patients. The MDA concentrations correlated positively with the TAC in the patients. It is concluded that the oxidative status of patients on HD is similar to that of patients on PD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [21] Comparison of the effect of hemodialysis and peritoneal dialysis in the treatment of end-stage renal disease
    Zhao, Yuan
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1562 - 1567
  • [22] Cardiac surgery in patients with end-stage renal disease on dialysis
    Back, Caroline
    Hornum, Mads
    Moller, Christian Joost Holdflod
    Olsen, Peter Skov
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (06) : 334 - 338
  • [23] Impact of dialysis modality on technique survival in end-stage renal disease patients
    Lee, Jong-Hak
    Park, Sun-Hee
    Lim, Jeong-Hoon
    Park, Young-Jae
    Kim, Sang Un
    Lee, Kyung-Hee
    Kim, Kyung-Hoon
    Park, Seung Chan
    Jung, Hee-Yeon
    Kwon, Owen
    Choi, Ji-Young
    Cho, Jang-Hee
    Kim, Chan-Duck
    Kim, Yong-Lim
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (01) : 106 - 115
  • [24] Permanent cardiac pacing in patients with end-stage renal disease undergoing dialysis
    Wang, I-Kuan
    Lin, Kuo-Hung
    Lin, Shih-Yi
    Lin, Cheng-Li
    Chang, Chiz-Tzung
    Yen, Tzung-Hai
    Sung, Fung-Chang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (12) : 2115 - 2122
  • [25] Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy
    Yang, Tsung-Lin
    Lin, Yi-Chun
    Lin, Yen-Chung
    Huang, Chun-Yao
    Chen, Hsi-Hsien
    Wu, Mai-Szu
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
  • [26] Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure
    Sens, Florence
    Schott-Pethelaz, Anne-Marie
    Labeeuw, Michel
    Colin, Cyrille
    Villar, Emmanuel
    KIDNEY INTERNATIONAL, 2011, 80 (09) : 970 - 977
  • [27] Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation
    Jagdale, Abhijit
    Cooper, David K. C.
    Iwase, Hayato
    Gaston, Robert S.
    XENOTRANSPLANTATION, 2019, 26 (02)
  • [28] Obese and diabetic patients with end-stage renal disease: Peritoneal dialysis or hemodialysis?
    Ekart, Robert
    Hojs, Radovan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 32 : 1 - 6
  • [29] Cardiac surgery in patients with end-stage renal failure
    Christiansen, S
    Claus, M
    Philipp, T
    Reidemeister, JC
    CLINICAL NEPHROLOGY, 1997, 48 (04) : 246 - 252
  • [30] Irinotecan in Cancer Patients with End-Stage Renal Failure
    Czock, David
    Rasche, Franz Maximilian
    Boesler, Benjamin
    Shipkova, Maria
    Keller, Frieder
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 363 - 369